A British biopharmaceutical company and vaccine maker has acquired Avidea Technologies, a biotechnology tenant at Johns Hopkins University’s FastForward incubation program, for $40 million.
A British biopharmaceutical company and vaccine maker has acquired Avidea Technologies, a biotechnology tenant at Johns Hopkins University’s FastForward incubation program, for $40 million.